The Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) in New Era of Personalised Medicine

Lung cancer is the leading cause of cancer related mortality in Canada and USA. Majority of the patients present in advanced stage of the disease and of these only about 2% will be alive at 5 years. NSCLC is the most common form of lung cancer, accounting for approximately 87% of cases. Systemic che...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Frontiers Research Topics
Glavni autori: Barbara Melosky, Vera Hirsh
Format: Livro
Jezik:Inglês
Izdano: Frontiers Media SA 2015
Teme:
R5-920
RC254-282
bic Book Industry Communication::M Medicine
Epidermal growth factor receptors
Non small cell lung cancer
Echinoderm microtubule associated protein like 4
Quality of Life
KRAS
Anaplastic lymphoma kinase
personalized medicine
Online pristup:https://directory.doabooks.org/handle/20.500.12854/61307
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items